Iterum Therapeutics (ITRMF) Q4 2019 Earnings Report

951 Followers

ITRMF Q4 2019 EPS Results

Actual EPS: -$23.85
Consensus EPS: ―
Beat/Miss: ―
One Year Ago EPS: -$25.80

ITRMF Q4 2019 Revenue Results

Actual Revenue: $0
Expected Revenue: ―
Beat/Miss: ―
YoY Revenue Growth: -100.00%

Earnings Announcement Details

Quarter: Q4 2019
Date: 03/12/2020
Time: Before Open
Conference Call: Thursday, March 12, 2020

ITRMF Upcoming Earnings

Iterum Therapeutics's next earnings date is estimated for November 12, 2026, based on past reporting schedules.

Q4 2019 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2019 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2019 Earnings Call Summary

No earnings call summary is available for this earnings event.

ITRMF Earnings History

ITRMF earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Nov 12, 2026	2026 (Q3)	―-	-0.16	―	―
Aug 07, 2026	2026 (Q2)	―-	-0.13	―
May 20, 2026	2026 (Q1)	―-	-0.1	―
Mar 12, 2026	2025 (Q4)	-0.14-0.20	-0.12	-66.67% (-0.08)
Nov 14, 2025	2025 (Q3)	-0.09-0.16	-0.24	33.33% (+0.08)
Aug 05, 2025	2025 (Q2)	-0.11-0.13	-0.23	43.48% (+0.10)
May 13, 2025	2025 (Q1)	-0.14-0.10	-0.38	73.68% (+0.28)
Feb 07, 2025	2024 (Q4)	-0.17-0.12	-0.81	85.19% (+0.69)
Nov 14, 2024	2024 (Q3)	-0.17-0.24	-1.2	80.00% (+0.96)
Aug 14, 2024	2024 (Q2)	-0.45-0.23	-0.77	70.13% (+0.54)
May 13, 2024	2024 (Q1)	-0.72-0.38	-0.58	34.48% (+0.20)
Mar 28, 2024	2023 (Q4)	-0.94-0.81	-0.66	-22.73% (-0.15)
Nov 14, 2023	2023 (Q3)	-0.88-1.20	-0.43	-179.07% (-0.77)
Aug 11, 2023	2023 (Q2)	-0.72-0.77	-0.45	-71.11% (-0.32)
May 12, 2023	2023 (Q1)	-0.71-0.58	-0.45	-28.89% (-0.13)
Mar 16, 2023	2022 (Q4)	-1.15-0.66	-0.3	-120.00% (-0.36)
Nov 10, 2022	2022 (Q3)	-1.00-0.43	-0.45	4.44% (+0.02)
Aug 12, 2022	2022 (Q2)	-0.90-0.45	-0.6	25.00% (+0.15)
May 13, 2022	2022 (Q1)	-0.60-0.45	-0.75	40.00% (+0.30)
Mar 28, 2022	2021 (Q4)	-0.60-0.30	-1.65	81.82% (+1.35)
Nov 12, 2021	2021 (Q3)	-0.60-0.45	-5.1	91.18% (+4.65)
Aug 13, 2021	2021 (Q2)	-0.90-0.60	-8.4	92.86% (+7.80)
May 14, 2021	2021 (Q1)	―-0.75	-13.5	94.44% (+12.75)
Mar 12, 2021	2020 (Q4)	―-1.65	-23.85	93.08% (+22.20)
Nov 16, 2020	2020 (Q3)	―-5.10	-32.25	84.19% (+27.15)
Aug 06, 2020	2020 (Q2)	―-8.40	-28.95	70.98% (+20.55)
May 14, 2020	2020 (Q1)	―-13.50	-21.6	37.50% (+8.10)
Mar 12, 2020	2019 (Q4)	―-23.85	-25.8	7.56% (+1.95)
Nov 12, 2019	2019 (Q3)	―-32.25	-18.6	-73.39% (-13.65)
Aug 14, 2019	2019 (Q2)	―-28.95	-33.3	13.06% (+4.35)
May 14, 2019	2019 (Q1)	―-21.60	-58.65	63.17% (+37.05)
Mar 25, 2019	2018 (Q4)	―-25.80	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Iterum Therapeutics earnings date